Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling ...

A stand-alone sequencing approach was accurate, cost effective and efficient for analyzing resistant pathogens and ...

Illumina is estimated to have around 80 ... “Element has taken the first step to democratise sequencing and will continue helping the community uncover the secrets of biology with high-quality ...

China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

Writing these steps and accounting for all the possibilities ... They start with Real-Time Analysis, which is needed for sequencing. They add Illumina Run Manager, which handles a lot of the run ...

Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...

Following the Jan. 13 announcement, Illumina shares jumped 5.5% to close at $144.22 on Monday. The company has democratized sequencing over the past 20 years, and with the progress in AI and ...

Q4 2024 Earnings Call Transcript February 6, 2025 Illumina, Inc. misses on earnings expectations. Reported EPS is $0.91 EPS, ...

For all of last year, Illumina’s net loss grew 5% from $1.161 billion to $1.223 billion, on revenue that fell 3% from $4.505 ...